Biomarkers, subtyping, and targeted-therapy

Explore the rapidly evolving role of biomarkers and molecular subtyping in the management of urologic malignancies. This focused evening program will highlight how advanced genomic and pathologic profiling is transforming precision diagnosis, risk stratification, and individualized treatment selecti